VASCULITIS CLINICAL RESEARCH CONSORTIUM (VCRC) STUDY OF CHURG-STRAUSS SYNDROME

血管炎临床研究联盟 (VCRC) 对 CHURG-STRAUSS 综合征的研究

• 批准号: 7608199
• 负责人: Carol Langford
• 金额: $ 0.06万
• 依托单位: CLEVELAND CLINIC LERNER COM-CWRU
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7608199
• 关键词: Asthma; Biological Markers; Blood; Chemicals; Churg-Strauss Syndrome; Clinical; Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Disease; Funding; Gene Proteins; Grant; Institution; Laboratory Research; Measures; Medical; Methods; Patients; Physicians; Purpose; Research; Research Personnel; Resources; Risk; Signs and Symptoms; Source; Specimen; Time; United States National Institutes of Health; Urine; Vasculitis; base

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. It is often difficult for both patients and physicians to determine how ¿active¿ a person¿s Churg-Strauss syndrome (CSS) is at any given time, yet it is critically important to determine disease activity in order to properly treat this disease. In CSS, this is further complicated by difficulties differentiating the activity of the underlying asthma from activity of the vasculitis component of the disease. Clinical signs and symptoms of disease are quite helpful but may be due to more than one medical problem. The purpose of this study is to use new scientific methods to discover new biological markers of disease activity in patiens with CSS that will serve one or more of the following uses: measure the amount of active disease occurring at any given time; predict what types of problems patients are at risk for in order to help choose the best therapy; and predict whether patients will respond to specific treatments. To help discover these new markers, we will follow a large group of patients with CSS at VCRC Vasculitis Centers over several years. Clinical information and blood and urine specimens will be collected on a regular basis. These specimens will be sent to research laboratories that are looking to discover new proteins, genes, and other chemicals that could serve as new ¿biomarkers¿.

这个子项目是众多研究子项目之一